IVT mRNA Production

Overview

mRNA provides new therapeutic opportunities for a range of diseases. In vitro transcribed (IVT) mRNA's versatility lies in several key features: simplified cell-free manufacturing, cell cycle independent performance, and insertional-mutagenesis risk-free.

The simple and expedited mRNA manufacturing workflow offers more opportunities for personalized medicines, such as patient-specific cancer vaccines or protein replacement for rare diseases.

GenScript’s solution to mRNA production streamlines your workflow starting from gene synthesis to IVT mRNA production. mRNAs produced at GenScript are optimized with our proprietary production platform, ensuring the quality and expression efficiency of your mRNA.

 

Why GenScript

Integrated Production Process

Service covering from gene to mRNA synthesis

 

Experienced Team with Optimized Production Platform

Save your time & effort in designing and making mRNA

 

Customized / off-the-shelf mRNA

Variety of choices to fulfill your research needs